Publishing research using ab58227? Please let us know so that we can cite the reference in this datasheet.
ab58227 has been referenced in 5 publications.
Lotan TL et al.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.Oncotarget 8:22772-22782 (2017).
Noh BJ et al.Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.Oncol Lett 11:3621-3630 (2016).
Tan HL et al.Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.Mod Pathol N/A:N/A (2014).
Cathomas R et al.Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07).Clin Cancer Res 18:6049-6057 (2012).
Lamontagne J et al.Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis.J Virol 84:907-17 (2010).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up